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Postnatal and adult human and monkey fibroblasts
were infected with Sendai virus containing the
Yamanaka factors for 24 hr, then they were cultured
in a chemically defined medium containing leukemia
inhibitory factor (LIF), transforming growth factor
(TGF)-b inhibitor SB431542, and glycogen synthase
kinase (GSK)-3b inhibitorCHIR99021at 39C for inac-
tivation of the virus. Induced neural progenitor (iNP)
colonies appeared as early as day 13 and can be
expanded for >20 passages. Under the same defined
condition, no induced pluripotent stem cell (iPSC)
colonies formed at either 37C or 39C. The iNPs pre-
dominantly expresshindbrain genes anddifferentiate
into hindbrain neurons, and when caudalized, they
produced an enriched population of spinal motor
neurons. Following transplantation into the forebrain,
the iNP-derived cells retained the hindbrain identity.
The ability to generate defined, integration-free iNPs
from adult primate fibroblasts under a defined condi-
tion with predictable fate choices will facilitate dis-
ease modeling and therapeutic development.
INTRODUCTION
Induction of pluripotent stem cells (iPSCs) from differentiated
somatic cells by defined transcription factors represents a major
breakthrough in cellular reprogramming (Takahashi and Yama-
naka, 2006; Takahashi et al., 2007; Yu et al., 2007). Extension
of this concept has led to transdifferentiation from one differen-
tiated cell type into another through overexpression of lineage-
related transcription factors (Caiazzo et al., 2011; Efe et al.,
2011; Huang et al., 2011; Ieda et al., 2010; Pang et al., 2011;
Pfisterer et al., 2011; Vierbuchen et al., 2010; Yoo et al., 2011).
Although those reprogrammed somatic cell populations offer
useful tools for understanding disease processes and discov-
ering therapeutics, they usually have little or no proliferation
potential, limiting their utilities. Direct conversion of somatic cells
to lineage-committed stem/progenitor cells, such as neural
stem/progenitor cells, would allow production of sufficient cells
for downstream research or application and overcome the
potential risk for tumor formation by iPSCs.1580 Cell Reports 3, 1580–1591, May 30, 2013 ª2013 The AuthorsRecently, neural stem/progenitor cells have been generated
from mouse fibroblasts by overexpressing Yamanaka factors
or neural transcription factors (Kim et al., 2011; Han et al.,
2012; Lujan et al., 2012; Thier et al., 2012). Similar neural stem
cells were also generated from human fibroblasts by retroviral-
mediated gene transduction (Kumar et al., 2012; Ring et al.,
2012). All these induced neural stem/progenitor (iNP) cells are
generated by the use of integrating lentiviruses or retroviruses,
which could disrupt endogenous gene expression and are asso-
ciated with the risk for tumor formation due to potential sponta-
neous reactivation of the viral transgenes (Okita et al., 2007).
Furthermore, the regional and functional identity of the iNPs
has not been carefully examined, limiting their utility. For applica-
tion in humans, it will be ideal and more practical to induce
patients’ somatic cells instead of fetal tissue into iNPs in an
integration-free manner.
In the present study, we generated iNPs from young and old
human and monkey fibroblasts using nonintegrating Sendai
(RNA) virus containing OCT4, SOX2, KLF4, and MYC (refer to
as OSKM). Infection with the Sendai virus (SeV) for 24 hr followed
by culturing in a chemically defined medium (CDM) containing
leukemia inhibitory factor (LIF), transforming growth factor
(TGF)-b inhibitor SB431542, and glycogen synthase kinase
(GSK)-3b inhibitor CHIR99021, and inactivation of the virus at
39C resulted in generation of neuroepithelial colonies as early
as day 13, but not iPSCs up to day 30. These integration-free
iNPs exhibit characteristic morphology, gene expression pat-
terns, growth rate, as well as predictable in vitro and in vivo
differentiation potentials. Importantly, the stable expandable
iNP lines carry a hindbrain identity and can differentiate into
hindbrain neurons and, when caudalized, an enriched population
of spinal cord motor neurons.
RESULTS
Human iNPs Are Generated from Postnatal and Adult
Fibroblasts by a Nonintegration Method
To generate human iNPs from nonfetal tissues with nonintegrat-
ing methods, we infected fibroblasts derived from three individ-
uals at different ages (cell line GM02504 from a 1-month-old
infant, cell line GM03815 from an adult, and cell line ND32947
from a 64-year-old adult; Table S1) with SeV containing four re-
programming factors (OSKM) or GFP (as a control). Twenty-four
hours later, the cultures were incubated at 39C, a condition that
facilitates the removal of SeV (TS15) (Ban et al., 2011). At the
Figure 1. Generation of iNPs from Human Fibroblasts
(A) Schematic representation of iNP generation process.
(B) Morphological changes during human iNP generation are shown. Fibro-
blasts were infected with SeV containing OSKM or GFP in the absence (upper
row) or presence (middle and lower rows) of LSC.
(C) A neural epithelium-like colony was observed in the OSKM+LSC group.
(D) Cells from selected colonies were SOX1+ (green), but NANOG (red).
Hoechst staining is blue.
(E) Q-PCR of existing SeV genomes in noninfected parent fibroblasts (SeV,
negative control), nine human iNP cell lines, and SeV-infected parent fibro-
blasts (SeV+, positive control). Data are represented as mean ± SEM.
(F) Q-PCR of human ESC markers (OCT4, NANOG, and REX1) during the re-
programming process (from the reprogramming experiments of fibroblast cell
Csame time, the medium was changed to a CDM supplemented
with recombinant human LIF, SB431542 (TGF-b inhibitor), and
CHIR99021 (GSK3b inhibitor) (refer to as LSC), a condition that
promotes long-term self-renewal of neural precursors (Li et al.,
2011) (Figure 1A). From day 3, the fibroblasts retracted their pro-
cesses and became square or round in morphology with a large
clear nucleus and two to three nucleoli in the OSKM group, but
not in the GFP group (Figure 1B, Day 3). On day 7, cell death
became obvious, and the surviving cells were reseeded as single
cells or small clusters on laminin-coated plates to form colonies.
On day 12, GFP disappeared, indicating loss of viral genes (Fig-
ure S1). We therefore switched the culture temperature back to
37C on day 13. At this stage, colonies with columnar epithelial
morphology were observed in the OSKM group treated with
LSC (Figure 1B, Day 13 OSKM+LSC), but not in either the
OSKM group not treated with LSC (Figure 1B, Day 13 OSKM)
or the GFP group treated with LSC (Figure 1B, Day 13
GFP+LSC). These colonies grew rapidly in the following week,
and by day 20, they were large enough to be selected manually
(Figure 1C). The selected neuroepithelial colonies, confirmed by
expression of neural stem cell marker SOX1 (Figure 1D), were
mechanically triturated into small cell clusters and plated onto
poly-L-ornithine (PO) and laminin-coated coverslips for immuno-
staining or onto laminin-coated 96-well-plates for cell expansion.
We obtained 25 and 20 SOX1-expressing colonies from the
fibroblast line GM02504 (two independent experiments), 22
and 21 SOX1-expressing colonies from the fibroblast line
GM03815 (two independent experiments), and 10 SOX1-
expressing colonies from fibroblast line ND32947, respectively
(Table S1). Hence, the efficiency of human iNP generation is
around 0.03%–0.08% as determined from the initial number of
fibroblasts used in the reprogramming experiments. Q-PCR
analysis indicated that SeV genomes were absent in the human
iNP lines (Figure 1E). Dropout experiments for the four trans-
genes OSKM showed that no iNP colony could be observed if
any one of the four transgenes was removed from the system
(data not shown), indicating that none of them is negligible in
this system. Dropout experiments for the three small molecules
LSC showed that omission of LIF did not affect the efficiency
of iNP generation but decreased the long-term expansion
capacity (Table S2). Thus, nonintegrating iNPs can be readily
generated from fibroblasts of human individuals with different
ages under the chemically defined conditions.
Given thatOSKMhavebeenused togenerate iPSCs,weasked
if iPSCsmaybegenerated under this condition. No iPSCcolonies
were observed at day 20 when the infected cells were cultured
in CDM (with LSC) on laminin-coated plates either at 37C or
39C. When the cultures were replaced with the conditioned
medium (CM) from g-radiated mouse embryonic fibroblastsline GM03815; data from other fibroblast cell lines follow the similar trends, not
shown). H9, human ESC line; Days 0–13, days after SeV infection. Data are
represented as mean ± SEM.
(G) Q-PCR of neural markers (SOX1 and N-Cadherin) during the reprogram-
ming process (from the reprogramming experiments of fibroblast cell line
GM03815; data from other fibroblast cell lines follow the similar trends, not
shown). Data are represented as mean ± SEM.
Scale bars, 50 mm (B and D). See also Figure S1 and Tables S1, S2, S5, and S6.
ell Reports 3, 1580–1591, May 30, 2013 ª2013 The Authors 1581
Table 1. Generation of iPSC and iNP Colonies under Different Culture Conditions
Culture Conditions Number of iPSC Colonies (Day 20/30) Number of iNP Colonies (Day 20)
Temperature Medium
GM02504 GM03815 R47 GM02504 GM03815 R47(Days 1–12) (Days 1–7) (Day 8)
37C CM CM 0/2 0/4 0/0 0 0 0
CDM 0/0 0/0 0/0 0 0 0
CDM CM 0/0 0/0 0/0 0 0 0
CDM 0/0 0/0 0/0 30 19 78
39C CM CM 0/0 0/0 0/0 0 0 0
CDM 0/0 0/0 0/0 0 0 0
CDM CM 0/0 0/0 0/0 0 0 0
CDM 0/0 0/0 0/0 25 22 57
37C FM CM+MEF 89/NA 157/NA 0/0 0 0 0
A total of 30,000 fibroblast cells were infected with SeV (OSKM) and cultured with different media (CM, CDM, or FM) for 1 week, then cells were re-
seeded onto laminin-coated or MEF-coated plates and cultured with different media (CM, CM, or CDM). CM, CM from g-radiated MEFs cultured in
human ESCM and with the treatment of 4 ng/ml FGF2; CM+MEF, cells reseeded onto MEF and cultured in CM; CDM, CDM with LSC; FM, fibroblast
growth medium (DMEM with 10% FBS); NA, not analyzed.(MEFs) cultured in human embryonic stem cell (ESC) culture
medium (ESCM) and with 4 ng/ml FGF2, a condition for gener-
ating iPSCs (Takahashi et al., 2007), we observed two to four
iPSC colonies when the cultures were maintained at 37C
throughout, but not at 39C from days 1 to 12 (Table 1). Q-PCR
analysis indicated that neural markers N-Cadherin and SOX1
were upregulated around the time of the first appearance of
iNP colonies, whereas the expression of pluripotent genes
NANOG and REX1 was not altered throughout the process with
a brief increased expression ofOCT4 (Figures 1F and 1G). These
results indicate that inactivation of SeV from day 1 to 12 and lack
of MEF CM and FGF prevent the formation of iPSC colonies.
Human iNPs Exhibit Characteristics of Neural
Progenitors
The iNPs displayed a columnar epithelial morphology and orga-
nized into a rosette form. However, the rosette did not have a
clear lumen (Figures 2A, 2B, S2A, and S2H), resembling the
primitive neuroepithelia generated from ESCs and iPSCs (Pan-
kratz et al., 2007). They expressed neural progenitor markers,
including NESTIN, SOX1, SOX2, FABP7, NOTCH1, PAX6, and
HES5, as shown by immunocytochemistry and RT-PCR (Figures
2C–2G, 2I, S2B–S2D, S2F, S2I–S2K, and S2M). The iNPs were
highly proliferative, as evidenced by expression of Ki67 in a large
proportion of the cells (65.3% ± 8.1%) (Figures 2H, S2E, and
S2L). Quantitative measurement of the population expansion
showed exponential growth of the iNPs over several passages
(Figures 2J, S2G, and S2N). These cells have now been
expanded for more than 20 passages, thus generating a large
amount (trillions) of cells. At passage 20, the iNP cell lines
retained a normal karyotype (Figure 2K). Thus, human iNPs
exhibit characteristics of neural progenitors.
Human iNPs Differentiate to Functional Neurons and
Glia In Vitro
To assess the differentiation potential, the iNPs were dissoci-
ated into single cells and cultured on laminin substrate in a1582 Cell Reports 3, 1580–1591, May 30, 2013 ª2013 The Authorsneural differentiation medium. After 60 days of differentiation,
process-bearing cells were obvious, and most of the cells
were Tuj1+ and MAP2+ neurons, some cells were GFAP+
astrocytes (Figures 3A and 3B), and less than 1% of cells
were Peripherin+ or Brn-3a+ neural crest cells (Figure S3). In
addition, iNP-derived neurons expressed synapsin along neu-
rites in a punctate manner (Figure 3A, arrowheads). The major-
ity of neurons were g-aminobutyric acid positive (GABA+)
(75.0% ± 2.5% of Tuj1+ cells), whereas few (1.1% ± 0.4% of
Tuj1+ cells) were TH+ (Figure 3C). However, O4+ oligodendro-
cytes were not observed in the culture (data not shown).
Because the majority of oligodendrocytes are derived from
ventral neural progenitors (Hu et al., 2009), we treated the
human iNPs with SHH (500 ng/ml) for 1 week. A small popula-
tion (8.3% ± 3.1% of total cells) of NKX2.2 and OLIG2 double-
positive preoligodendrocyte precursor cells (pre-OPC) was
observed in the culture (Figure 3D). When further culturing in
the glial differentiation medium for 10 weeks, O4+ oligodendro-
cytes were detected (Figure 3E).
The functional properties of iNP-derived neurons were
analyzed by whole-cell patch-clamp recordings on cultures
after 10 weeks of differentiation (Figure 3F). In the 12 neurons
tested, the mean cell capacitance (Cap) was 35.2 ± 4.5 pF,
resting membrane potential (RMP) was 47 ± 6 mV, and the
spontaneous action potential frequency (APs Freq.) was 2.6 ±
0.2 Hz (Figure 3Fb). Both inward Na+ and outward K+ currents
were observed in these cells by voltage clamp (Figure 3Fc).
Action potentials can be triggered by injection of current steps
from 60 to +60 pA (Figure 3Fd). Neurons displayed a low
rate of spontaneous action potential spikes with a slow,
subthreshold oscillatory potential (30 mV, Figure 3Fe). The
spontaneous postsynaptic responses were observed, indi-
cating formation of functional synaptic network with surround-
ing neurons (Figure 3Ff). The synaptic activity was partially
blocked by CNQX and further eliminated by combination of
CNQX and bicuculline (Figure 3Ff) unveiling the excitatory
(glutamatergic) and inhibitory (GABAergic) neurotransmission
Figure 2. Characterization of Human iNPs
(A) Phase-contrast image for established human iNP cell line 15-LA-24 (passage 5).
(B) High-magnification image of cells in the inset in (A).
(C–G) Human iNPswere stained positively for NESTIN (C, green), SOX1 (D, red), SOX2 (E, red), FABP7 (F, green), andNOTCH1 (G, green). Hoechst staining is blue.
(H) Immunostaining for Ki67 (red). Hoechst staining is blue.
(I) RT-PCR shows human iNPs expressed neural progenitor markers: SOX1, SOX2, FABP7, PAX6, and HES5. GAPDH was used as an internal control. RNA was
extracted from noninfected parent fibroblasts (Fibroblasts, negative control), three human iNP cell lines (GM15-LA-24, GM15-LA-25, and GM15-LA-01), early
passage (passage 5), and late passage (passage 20) of human iNP cell line GM15-LA-24.
(J) Growth curve of human iNP cell lines GM15-LA-24, GM15-LA-25, and GM15-LA-01. Cells at passage 5 were used as initial cells.
(K) Representative karyotype of human iNP cell line 15-LA-24 at passage 20.
Scale bars, 50 mm (A–H). See also Figure S2 and Tables S5 and S6.inputs, respectively. Thus, the iNPs possess the potential to
differentiate into astrocytes, oligodendrocytes, and functional
neurons in vitro.
iNPs Can Be Generated from Monkey Fibroblasts in a
Similar Manner
To assess whether other primate fibroblasts could also be re-
programmed into iNPs in a similar manner and to build a primate
model for assessing disease process and cell therapy throughCautologous transplantation, we obtained fibroblasts from an
8-year-old rhesus monkey (Xi et al., 2012) and repeated the
experiments described above. As shown in Figure 4, monkey
iNPs can be similarly generated from fibroblasts, and the iNPs
can differentiate into functional neurons and glial cells in vitro.
It is interesting to note that whereas iPSCs were generated
from the monkey fibroblasts with retroviral methods (Xi et al.,
2012), they were not produced with the SeV under the conven-
tional culture condition (Table 1).ell Reports 3, 1580–1591, May 30, 2013 ª2013 The Authors 1583
Figure 3. In Vitro Differentiation Potential of Human iNPs
(A) Human iNP-derived neural cells showed typical neuronal morphology and expressedmarkers both for neurons (Tuj1, MAP2, and synapsin) and for astrocytes
(GFAP) after 60 days of differentiation.
(B) Quantification of MAP2+ neurons and GFAP+ astrocytes among total cells. Data are represented as mean ± SEM.
(C) The major population of human iNP-derived neurons was GABA+, and only a small population of neurons was TH+.
(D) NKX2.2 (green) and OLIG2 (red) double-positive pre-OPCs were observed in the culture of human iNPs treated with SHH (500 ng/ml) for 1 week.
(E) After 10 weeks of differentiation in the glial differentiation medium, O4+ oligodendrocytes were observed in cultures that were treated with SHH (500 ng/ml).
(F) Physiological properties of human iNP-derived neurons assessed by whole-cell patch-clamp recordings. (a) Whole-cell recording on a neuron cultured for
10 weeks in vitro. (b) Electrophysiological characteristics of human iNP-derived neurons. (c) Inward Na+ and outward K+ currents were triggered upon 50
to +50 mV voltage steps. The initial currents were enlarged in the inset panel. (d) Action potentials were induced from 60 to +60-pA-injected current steps.
(e) Neurons displayed a low rate of spontaneous action potential spiking with a subthreshold oscillatory potential (30mV). (f) Both excitatory (inward current) and
inhibitory (outward current) spontaneous postsynaptic currents were recorded when neurons were held at 0 mV. The excitatory responses were eliminated after
treatment with CNQX, and the inhibitory responses were further eliminated upon the presence of additive bicuculline in the extracellular solution. The asterisks
indicate individual excitatory (sEPSCs) and inhibitory (sIPSCs) events.
Scale bars, 50 mm (A, C, D, and E). See also Figure S3 and Table S6.Human iNPsCanBePatterned toRegion-SpecificNeural
Subtypes
Neural progenitors differentiated from PSCs often carry a spe-
cific regional identity depending on the presence of morpho-
gens. We asked if the iNPs carry a particular regional identity
under the culture condition. The isolated iNP colonies were
expanded to multiple new colonies for 1 week (refer to as pas-1584 Cell Reports 3, 1580–1591, May 30, 2013 ª2013 The Authorssage 1) and stained for homeodomain markers. We found that
the new colonies were either stained positive for forebrain
markers FOXG1 and/or OTX2 or hindbrain markers HOXA2
and/or HOXB4, but not for midbrain marker EN1 (Figures S4A–
S4H; Table S3; data not shown). After around 1month expansion
(passage 5), all iNP colonies lost their anterior identity and uni-
formly showed posterior identity. RT-PCR and immunostaining
showed that the human iNP cell lines at passage 5 and passage
20 predominantly expressed hindbrainmarkers, includingGBX2,
KROX20, HOXA2, HOXA3, and HOXB2, but not forebrain (such
as FOXG1, EMX1, and OTX2), midbrain (such as PAX2 and
EN1), or spinal cord (such as HOXB6 and HOXB8) markers (Fig-
ures 5A, 5D, and S4I). The stable human iNP lines also predom-
inantly expressed markers in the dorsal and middle parts of the
hindbrain, including PAX7, IRX3, PAX6, and NKX6.1, but not
markers of the ventral hindbrain, including OLIG2 and NKX2.2
(Figures 5B, 5E, and S4I). Therefore, the stable iNP lines are
predominantly dorsal hindbrain progenitors. This pattern of
homeodomain gene expression was retained when comparing
cells from late stage (passage 20) to those from early stage
(passage 5) (Figure S4I), indicating the maintenance of the iNP
regional identity over cellular expansion.
We then asked if such a regional fate may be altered by treat-
ing the stable iNP lines with morphogens. Although treatment of
early-stage iNPs (at passage 1) with FGF8b (100 ng/ml) plus SHH
(200 ng/ml) drove some of the clones to expressmidbrainmarker
EN1, treatment of iNPs (at passage 5) with FGF8b or FGF8b plus
SHH did not drive the human iNPs to express forebrain or
midbrain markers (Table S4; data not shown). However, addition
of posterior patterning reagent retinoic acid (RA; 0.1 mM) turned
off the expression of HOXA2 but turned on the expression of
HOXB4 (Figures 5A and 5D), suggesting the acquisition of the
upper spinal cord fate. When treated with a high dosage of
SHH (1,000 ng/ml), the human iNPs were ventralized by express-
ing the ventral hindbrain marker NKX2.2 (Figures 5B, 5E, S4J,
and S4K). Treatment with both RA (0.1 mM) and SHH (500 ng/
ml) resulted in more than 80% human iNP cells to express
OLIG2 and HOXB4, indicative of spinal cord motor neuron pre-
cursors (Figures 5C and 5F). Indeed, with further differentiation
of RA and SHH-treated iNPs, a large proportion of the Tuj1+ neu-
rons expressed ISLET1, HB9, and ChAT (Figures 5G and 5H),
indicative of motor neurons; with further differentiation of SHH
(1,000 ng/ml)-treated iNPs, some neurons expressed a serotonin
neuronal marker 5-HT (Figures 5G and 5I). It is noted that during
long-term passaging, all human iNP cell lines gradually lost the
capability of being respecified, and fewer and fewer cells were
patterned to NKX2.2+ ventral cells or OLIG2+ spinal cord cells
(Figures S4L–S4O; data not shown). Together, these results indi-
cate that the iNPs are of dorsal hindbrain identity but can be
respecified to ventral and more caudal neural types and further
differentiate into hindbrain neurons and an enriched population
of spinal cord motor neurons.
Human iNPs Generate Neurons and Glia and Maintain
the Hindbrain Identity In Vivo
To assess the in vivo differentiation potential of human iNPs, the
iNP cell line 15-LA-24 (at passage 5), which was derived from
fibroblast cell line GM03815, was transplanted into the forebrain
of newborn mice (Figure 6). One month after transplantation,
most of the grafted cells, identified by human-specific antibody
STEM121, were found in the ventricle (n = 6 mice) (Figure 6A).
The majority of the grafted cells were Tuj1+ neurons (Figure 6C).
Some cells expressed GFAP, as indicated by a human-specific
GFAP antibody STEM123, indicating astrocytes (Figure 6E).
However, few cells were NeuN+ mature neurons, and noCMBP+ oligodendrocytes were observed (Figures 6G and 6I).
Four months after transplantation, some grafted cells migrated
into the parenchyma in the subventricular area (n = 8 mice) (Fig-
ure 6B, inset). In addition to Tuj1+ neurons (Figure 6D) and
GFAP+ astrocytes (Figure 6F), some human cells became posi-
tive for NeuN (Figure 6H, arrowheads; Figure S5A), indicative of
neuronal maturation. Furthermore, patches of MBP+ profiles
were also detected in the grafts, suggestive of myelination (Fig-
ures 6J and S5B). Because human PSC-derived OPCs often
become mature oligodendrocytes and produce myelin sheaths
3–4 months after transplantation (Hu et al., 2009), we observed
MBP staining in some fibers as well as some cell bodies (Fig-
ure 6J). More importantly, even though cells were transplanted
into the forebrain for 4 months, most of the cells still expressed
hindbrain markers HOXA2 and HOXB4, but not forebrain
markers FOXG1 or OTX2 (Figures 6K–6N). No Ki67+ human cells
were observed in the graft, and no tumors were found in themice
4 months posttransplantation. Thus, human iNPs possess the
potential to differentiate into mature neurons, astrocytes, and
oligodendrocytes and keep the hindbrain identity in vivo.
DISCUSSION
In this study, we have developed a strategy for generation of
iNPs from human and monkey individuals at different ages
using the nonintegrating SeVs. Importantly, these iNPs can
be expanded to a large amount in a CDM with a cocktail of
growth factors and small molecules but without the presence
of viral and reprogramming genes. The expanded iNPs stably
carry the predictable dorsal hindbrain identity. Interestingly,
this regional identity can be modified to produce more caudal
cell types, including enriched populations of spinal motor
neurons. Upon removal of the growth factor cocktail or trans-
plantation into the mouse brain, the iNPs differentiate into
astrocytes, oligodendrocytes, and functional neurons, and they
retain the expected hindbrain identity. These results open the
possibility of generating consistent and predictable iNPs from in-
dividuals for drug discovery and potential cell therapy.
The Yamanaka factors are generally used to induce pluripo-
tency. Our study was hence based on the hypothesis that neural
progenitorsmaybederivedduring theprocessof pluripotency in-
duction, although mouse fibroblasts were reported to convert to
neural stem cells by bypassing the iPSC stage using the same
factors (Kim et al., 2011). To our surprise, the iNP colonies were
observable as early as day 13, whereas no iPSC colonies form
3–4 weeks after viral infection under the chemically defined con-
dition or even with the addition of MEF CM and FGF2, a culture
condition for ESCs and iPSCs. It has been shown that the exog-
enous transgenes need to be expressed for at least 12 days in
order to generate mouse iPSCs (Brambrink et al., 2008). In our
culture system, we raised temperature to remove transgenes
1 day after infection for 12 days, which potentially disturbed the
process of iPSC generation. Furthermore, the expression of
pluripotent genes, Nanog and Rex1, was not significantly acti-
vated throughout the process.We reason that the lack of upregu-
lation of pluripotent genes is likely due to our unique induction
condition in which the viral genes are being inactivated by raised
temperature, and the infected cells are grown in a chemicallyell Reports 3, 1580–1591, May 30, 2013 ª2013 The Authors 1585
Figure 4. Generation and Characterization of iNPs from Monkey Fibroblasts
(A) A SOX1+ (green) and NANOG (red) neuroepithelial colony was observed in the reprogramming culture from monkey fibroblasts.
(B) Phase-contrast image of monkey iNPs. Inset is the high-magnification image.
(C–F) Monkey iNPs were NESTIN+ (C, green), SOX1+ (D, red), SOX2+ (E, red), and FABP7+ (F, green).
(G) Immunostaining for Ki67 (red).
(legend continued on next page)
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defined condition from day 1. This is supported by the fact that
iPSC colonies indeed formed when the cultures weremaintained
at 37C and supplemented with MEF CM and FGF2. Therefore,
the formation of iNPs under our present culture condition is
unlikely going through the pluripotent stage. This conclusion is
further supported by the fact that when the infected cells were
cultured in MEF CM and FGF2 for the first week and then re-
seeded in CDM (with LSC), no iNPs could be observed (Table 1).
Taken together, these results suggest that generation of iPSCs
under our chemically defined condition at 39C within 2 weeks
is very unlikely and that iNPs are most likely generated by direct
conversion rather than through rapid differentiation of iPSCs.
Although iPSCs have been established using nonintegrating
methods (Ban et al., 2011; Okita et al., 2008; Stadtfeld et al.,
2008; Yusa et al., 2009; Zhou et al., 2009), direct conversion of
fibroblasts to neurons or iNPs, especially the maintenance of
iNPs, often depends on the presence of reprogramming genes.
Hence, the methods employed are largely based on integrating
viruses to date (Han et al., 2012; Kim et al., 2011; Lujan et al.,
2012; Ring et al., 2012; Thier et al., 2012). One of the potential
reasons is lack of a condition that would support the survival
and/or maintenance of dedifferentiated or reprogrammed iNPs.
Indeed, in the presence of the LSC cocktail, which has been
shown by Ding’s group to sustain the long-term self-renewal of
human ESC-derived neural stem cells (Li et al., 2011), iNPs
have been consistently generated with the nonintegrating SeV
from fibroblasts of both human and monkey at various ages
(human) in this study. The importance of the LSC cocktail is
also evident by the lack of iNP colonies in the cultures without
the LSC cocktail (Figure 1B). The presence of LSC cocktail, how-
ever, has driven the iNP cells to acquire a hindbrain fate, which is
quite different from the human ESC-derived neural stem cells re-
ported by Ding’s group (Li et al., 2011). In Ding’s report, the neu-
ral stem/progenitor cells differentiated from ESCs under the
same LSC cocktail carry a forebrain/midbrain fate by expressing
Forse1 and OTX2 (Li et al., 2011). It is not clear why there is such
a discrepancy. We have also differentiated human ESCs/iPSCs
under the LSC cocktail, and the resultant neural progenitors
almost always carry a hindbrain character. We reason that
besides its proliferative effect, CHIR also exerts its dose-depen-
dent caudalizing (patterning) effect as indicated by us and others
(Kirkeby et al., 2012; Xi et al., 2012). That explains why at the for-
mation of iNP colonies some carry forebrain/midbrain markers,
but they quickly become stable hindbrain progenitors.(H) Growth curve from monkey iNP cell lines (47-LA-01, 47-LA-05, 47-LA-11) and
passage 5 were used as initial cells.
(I) Q-PCR of existing SeV genomes in noninfected parent fibroblasts (Fibroblast,
and SeV-infected human fibroblasts (SeV, positive control). Data are represented
(J) Monkey iNP-derived neural cells showed typical neuronal morphology and exp
(GFAP) after 8 weeks of differentiation. O4+ oligodendrocytes were observed in
(K) Physiological properties of monkey iNP-derived neurons assessed by whole-
in vitro. (b) Electrophysiological characteristics of monkey iNP-derived neurons.
voltage steps. The initial currents were enlarged in the inset panel. (d) Action po
displayed a low rate of spontaneous action potential spiking with a subthreshold
(outward current) spontaneous postsynaptic currents were recorded when neuron
with CNQX, and the inhibitory responses were further eliminated upon the pre
individual excitatory (sEPSCs) and inhibitory (sIPSCs) events.
Scale bars, 50 mm (A–G and J).
CNeural stem/progenitor cells often change their identities over
the course of in vitro expansion. One important feature of the
human and monkey iNPs generated in the present study is their
stable phenotypes after long-term expansion. In particular, the
dorsal hindbrain identity is not altered even after 20 passages.
This allows generation of large quantities of uniform cell popula-
tions with predictable phenotypes. The conversion and mainte-
nance of the iNP phenotype are likely due to the LSC cocktail,
especially CHIR99021, the GSK3b inhibitor. It has been shown
that inhibition of GSK3b renders neural progenitors in the entire
neuraxis in a state of self-renewal (Kim et al., 2009). The dorsal
hindbrain identity of the iNPs is likely due to the effect of
CHIR99021 on WNT. By inhibiting GSK3b, CHIR99021 activates
theWNTpathway (FrameandCohen, 2001), thuscaudalizingand
dorsalizing the iNPs. Indeed, we and others have shown that
CHIR99021 induces the mid-hindbrain phenotypes of human
ESC- and iPSC-derived neuroepithelia in a dose-dependent
manner (Kirkeby et al., 2012; Kriks et al., 2011; Xi et al., 2012).
In that regard, it will be interesting to identify a condition that
would induce/maintain iNPswithout altering the regional identity.
The dorsal hindbrain phenotype acquired during the iNP gen-
eration and expansion appears permanent because treatment
with FGF8b does not push the cells back to the telencephalic
or mesencephalic fate. Nevertheless, our iNPs retain the ability
to be respecified to more caudal fates. In particular, with the
combined treatment of RA and SHH, the iNPs are specified to
OLIG2+ and HOXB4+ spinal motor neuron progenitors, which
subsequently become an enriched population of spinal cord
motor neurons. This phenomenon suggests that if a specific
cocktail is applied during reprogramming, iNPs with a particular
regional identity and predictable differentiation potential may
be generated. This will allow generation of large quantities of
custom-designed iNPs, facilitating drug testing and potential
application in cell therapy. It should be noted that the iNPs
gradually lose their ability to be respecified to other fates during
long-term passaging (>20). This indicates that a simple culture
cocktail without persistent transgene expressionmay not be suf-
ficient to maintain the ‘‘plasticity’’ of the iNPs even though the
iNPs can still be expanded. This phenomenon also suggests
that perhaps we could ‘‘fix’’ the identity of the iNPs early on,
thus increasing the predictability of the fate of iNPs.
iNPs have been generated frommouse fibroblasts. In humans,
some samples were used to generate iNPs by the retroviral
approach (Kumar et al., 2012; Ring et al., 2012). Although singlefrom human iNP cell lines (GM15-LA-24, GM15-LA-24, GM15-LA-24). Cells at
negative control), three monkey iNP cell lines (47-LA-01, 47-LA-05, 47-LA-11),
as mean ± SEM.
ressedmarkers both for neurons (Tuj1, MAP2, and synapsin) and for astrocytes
differentiation cultures from ventralized monkey iNPs.
cell patch-clamp recordings. (a) Whole-cell recording on a neuron at 10 weeks
(c) Inward Na+ and outward K+ currents were triggered upon 50 to +50 mV
tentials were induced from 60 to +60-pA-injected current steps. (e) Neurons
oscillatory potential (30 mV). (f) Both excitatory (inward current) and inhibitory
s were held at 0 mV. The excitatory responses were eliminated after treatment
sence of additive bicuculline in extracellular solution. The asterisks indicate
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Figure 5. Identity and Generation of Region-Specific Progenitors and Neurons from iNPs
(A) Human iNPs predominantly expressed hindbrain marker HOXA2, and only a small portion of cells expressed marker for posterior hindbrain or spinal cord
(HOXB4), but not anterior markers FOXG1, OTX2, and EN1.When treated with FGF8b (100 ng/ml, FGF8b-iNP), the regional identity was not altered. When treated
with RA (0.1 mM, RA-iNP), human iNPs were posteriorly patterned and predominantly expressed marker for posterior hindbrain or cervical spinal cord (HOXB4).
Insets show positive controls for FOXG1, OTX2, and EN1, respectively.
(B) Human iNPs predominantly expressed marker for dorsal (PAX3/PAX7) and marker for middle part of hindbrain (PAX6), and only a small portion of cells
expressed marker for ventral hindbrain (NKX6.1). When treated with SHH (1,000 ng/ml, SHH-iNP), human iNPs were ventrally patterned and predominantly
expressed markers for ventral hindbrain (NKX6.1 and NKX2.2).
(C) When treated with RA (0.1 mM) and SHH (500 ng/ml) (RA+SHH-iNP), most human iNP cells became OLIG2+ and HOXB4+ spinal cord motor neuron
precursors.
(D) Quantification of cells expressing HOXA2 and HOXB4 in (A). Data are represented as mean ± SEM.
(E) Quantification of cells in (B). Data are represented as mean ± SEM.
(F) Quantification of cells in (C). Data are represented as mean ± SEM.
(G) Quantification of cells in (H) and (I). Data are represented as mean ± SEM.
(legend continued on next page)
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Figure 6. In Vivo Differentiation Potential of
Human iNPs
(A, C, E, G, and I) One month posttransplantation,
human cells, stained for STEM121, were present in
the lateral ventricle (A) and were positive for Tuj1
(C), GFAP (E) but rarely for NeuN (G), and not for
MBP (I).
(B, D, F, H, and J) Four months post-
transplantation, the human cells were also in
parenchyma tissues near the ventricle (B) and
were positive for Tuj1 (D), GFAP (F), NeuN (H,
arrowheads), and MBP (J, arrows indicate MBP+
fibers).
(K–N) Four months posttransplantation, the
human cells were detected as FOXG1- (K), OTX2-
(L), HOXA2+ (M), and HOXB4+ (N).
Nuclei were stained with Hoechst (blue). Scale
bars, 200 mm (A and B) and 50 mm (C–N). See also
Figure S5 and Table S6.transgene (SOX2) seems sufficient to generate iNPs from fetal
foreskin tissue samples via retroviral infection (Ring et al.,
2012), there still exist the risks for disruption of endogenous
gene expression and tumor formation due to potential sponta-
neous reactivation of the viral transgenes (Okita et al., 2007).
Most recently, Pei and colleagues reported generation of iNPs
from urine cells of humans (10, 25, and 37 years) using a similar
nonintegrating method (oriP/EBNA episomal vectors) for a(H) The major neuronal population in the RA and SHH-treated iNP cultures (RA+SHH-iNP-Neurons) was HB9+
(I) The ventralized neural progenitors differentiated to ISLET1+, HB9+, and 5-HT+ ventral neurons (SHH-iNP
Cell nuclei were stained with Hoechst (blue).
Scale bars, 50 mm (A–C, H, and I). See also Figure S4 and Tables S3 and S6.
Cell Reports 3, 1580–159similar period (12 days) (Wang et al.,
2013). The finding coincides with our
report. In that report, they used a set of
six factors that have been used for iPSC
generation (Li et al., 2009), and the iNPs
were generated on Matrigel without
raising temperature to inactivate the
transgenes. Interestingly, it is stated in
the report that that protocol does not
apply to human dermal fibroblasts. It is
not clear why they could not generate
iNPs from dermal fibroblasts because
our dropout analysis indicated that only
three factors (LSC) are sufficient. More
importantly, that report does not address
if the iNPs are generated through direct
conversion or via iPSCs, nor does it
analyze the regional identity and the plas-
ticity of the iNPs, key issues addressed in
our present report.
The strategy described in the present
study allows efficient generation of iNPs
(for human cells, 0.03%–0.08%; for mon-
key cells, around 0.19%) from primate
species by a nonintegrating method.This will make it possible to generate iNPs from patients’ skin
tissues directly. We chose SeV because to date, there is no
report of pathogenicity associated with SeV in primates, and
its safety could be further enhanced by the F-deficiency (Nagai
et al., 2011). SeV-based vector has been used in clinical gene
therapy for cystic fibrosis (Ferrari et al., 2007; Yonemitsu et al.,
2000) and vaccine delivery (Takeda et al., 2008). Additionally,
the temperature-sensitive nature of the RNA virus (Ban et al.,, ISLET1+, and ChAT+ spinal cord motor neurons.
-Neurons).
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2011) offers another safeguard step to ensure removal of viral
genomes, as shown in the present study. Therefore, our trans-
gene integration-free and expandable primate iNPs provide a
safe and robust cellular platform for the generation of patient-
specific neural cells for biomedical applications.
EXPERIMENTAL PROCEDURES
Generation of iNPs from Human and Monkey Fibroblasts
Information for human and monkey fibroblasts is summarized in Table S1, and
the process for iNP generation is shown in Figure 1A. NIH guidelines for labora-
tory animal care and safety were strictly followed. On day1, around 30,000 fi-
broblasts were seeded in one well of a 24-well-plate (Nunc) and cultured in the
fibroblast medium (FM; Dulbecco’s modified Eagle’s medium [DMEM] supple-
mentedwith10%FBS).Onday0, thefibroblastswere infectedwithSeVs (TS15)
containingOSKM,orGFP (kindlyprovidedbyDNAVEC,Japan) according to the
manufacturer’s instruction. On day 1, themediumwas changed to a CDM con-
sisting of DMEM/F12: Neurobasal (1:1), 13N2, 13B27, 1%GlutaMAX (all from
Life Technologies). In some cultures, 10 ng/ml recombinant human LIF, 3 mM
CHIR99021, and 2 mM SB431542 (all from Stemgent) were added. All the cul-
tures were incubated at 39C. On day 7, the cells were dissociated with EDTA
in the presence of ROCK inhibitor (Y-27632, 5 mM; Tocris Bioscience) and
then reseeded onto one well of a 6-well-plate (Nunc), which was precoated
with laminin (Life Technologies). On day 13, GFP, an indicator of viral presence,
disappeared, and neuroepithelium-like colonies began to appear in the culture.
The cultures were then transferred back to 37C. On day 20, cell colonies were
selected, mechanically triturated into small clusters, and reseeded onto PO
(Sigma-Aldrich) and laminin-precoated12mmglass coverslip for immunostain-
ing or laminin-coated 96-well-plates for cell expansion. iNP cells were passed
on laminin-coated plates and cultured in the samemedium used for the gener-
ation of iNPs. Human ESCmedium used in the studywas composed of DMEM/
F12 containing 20% knockout serum replacement (KSR; Life Technologies),
1% GlutaMAX, 1% Nonessential Amino Acids (NEAA; Life Technologies),
0.1 mM 2-ME (Life Technologies), and 4 ng/ml bFGF (PeproTech).
Regional Patterning and Neural Differentiation of iNPs
To pattern the iNPs, LSC were removed from CDM, and morphogens were
added to the culture for 1 week, including FGF8b (PeproTech; 100 ng/ml),
RA (Sigma-Aldrich; 0.1 mM), and/or SHH (C24II, R&D Systems; 200–
1,000 ng/ml). For terminal differentiation, iNPs were seeded at a density of
10,000–15,000 cells per 12 mm glass coverslip that was coated with PO and
laminin in a neural differentiation medium (Neurobasal with 13 N2, 13 B27,
13NEAA supplemented with 1 mg/ml laminin, 0.2mM vitamin C [Tocris Biosci-
ence], 300 ng/ml cAMP [Sigma-Aldrich], 10 ng/ml GDNF, 10 ng/ml BDNF, and
10 ng/ml IGF-I [all from PeproTech]). For oligodendrocyte differentiation, glia
differentiation medium was applied as described before by Hu et al. (2009).
Briefly, SHH-treated iNPs were seeded at a density of 10,000–15,000 cells
per 12 mm glass coverslip that was coated with PO and laminin in a glial
differentiation medium (DMEM:F12, N1 supplement, T3 [60 ng/ml], biotin
[100 ng/ml], and cAMP [1 mM] [all from Sigma-Aldrich] supplemented with a
cocktail of cytokines consisting of the PDGF-AA isoform, insulin-like growth
factor 1 [IGF1], and neurotrophin 3 [NT3] [all at 10 ng/ml from R&D Systems]).
RNA Extraction and RT-PCR
RNA extraction and RT-PCR analysis were described before (Zhang et al.,
2010). To compare theexpression level of different genes, probeswere normal-
ized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) by performing
15, 20, and 25 cycles. PCR conditions and cycle numbers were established
byusingcommercially availablehuman fetal brain (singledonor,male, 19weeks
of gestation) (Agilent Technologies). Q-PCRwas performedby using the Power
SYBR Green kit (Applied Biosystems, UK). Primers are listed in Table S5.
Immunocytochemistry
Immunostaining was performed as described previously (Zhang et al., 2010).
In brief, cells were fixed in 4% neutral-buffered paraformaldehyde (PFA) for
20 min at room temperature. For detection of GABA, 0.05% glutaraldehyde1590 Cell Reports 3, 1580–1591, May 30, 2013 ª2013 The Authors(Electron Microscopy Sciences) was included in the fixative. All antibodies,
sources, and dilutions are listed in Table S6. Cell populations were counted
among total cells (Hoechst labeled) or neurons (Tuj1+) using the ImageJ soft-
ware. At least five fields of each coverslip were chosen randomly, and three
coverslips in each group were counted. Data were expressed as mean ± SEM.
Electrophysiology
Whole-cell patch-clamp recordings were performed on human ormonkey iNP-
derived neurons after 10 weeks of differentiation, as previously described by
Ma et al. (2012).
Cell Transplantation and Histology
Transplantation studies were conducted following protocols approved by the
Animal Care and Use Committees at the University of Wisconsin-Madison.
iNPs (105 cells in 2 ml artificial cerebral spinal fluid, Harvard Apparatus) were
injected 1 mm from the midline between the bregma and lambda and 1 mm
deep into the lateral ventricles of both hemispheres of newborn severe com-
bined immunodeficiency (SCID)-beige (Taconic) mice. One and 4months after
transplantation, animals were processed for histological analysis as described
before by Ma et al. (2012). All antibodies, sources, and dilutions are listed in
Table S6.
Statistical Analysis
Values were expressed as mean ± SEM. Differences between means were
assessed by t test. A p value <0.05 was considered statistically significant.
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